Tooth showdown: which pulp capping material wins?

NCT ID NCT07147036

Completed Disease control Sponsor: Zahoor khan Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested two materials, Biodentine and Calcium Hydroxide, placed under fillings to protect the tooth nerve in 76 adults with reversible pulpitis. Over 12 weeks, researchers checked pain, X-ray changes, and nerve responses to see which material better kept the tooth alive and healthy. The goal is to find a more effective way to treat deep cavities without needing a root canal.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Biodentine and Calcium Hydroxide
What this could lead to: If successful, this could show that Biodentine is a better material for preserving tooth vitality and reducing pain after cavity treatment.
What could go wrong: This is a small, completed study with only 76 participants, so results may not apply to everyone. The follow-up is short (12 weeks), so long-term success is unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for REVERSIBLE PULPITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pulpitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

REVERSIBLE PULPITIS

Contacts and locations

Locations

HITEC-IMS Taxila

Rawalpindi, Punjab Province, 47080, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.